Endocrine and metabolic complications of COVID-19: lessons learned and future prospects A Esmaeilzadeh, R Elahi, A Siahmansouri, AJ Maleki, A Moradi Journal of Molecular Endocrinology 1 (aop), 2022 | 16 | 2022 |
Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks A Esmaeilzadeh, AJ Maleki, A Moradi, A Siahmansouri, MJ Yavari, ... Expert Review of Vaccines 21 (10), 1377-1394, 2022 | 14 | 2022 |
Chimeric antigen receptor (CAR)-based cell therapy for type 1 diabetes mellitus (T1DM); current Progress and future approaches V Mohammadi, AJ Maleki, M Nazari, A Siahmansouri, A Moradi, R Elahi, ... Stem Cell Reviews and Reports 20 (3), 585-600, 2024 | 5 | 2024 |
EG. 5 (Eris) and BA. 2.86 (Pirola) two new subvariants of SARS-CoV-2: a new face of old COVID-19 A Esmaeilzadeh, F Ebrahimi, A Jahani Maleki, A Siahmansouri Infection 52 (2), 337-343, 2024 | 4 | 2024 |
Targeting the cGAS-STING pathway as an inflammatory crossroad in coronavirus disease 2019 (COVID-19) R Elahi, S Hozhabri, A Moradi, A Siahmansouri, A Jahani Maleki, ... Immunopharmacology and Immunotoxicology 45 (6), 639-649, 2023 | 4 | 2023 |